These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1000 related articles for article (PubMed ID: 26810565)
21. [Cardiac Structural and Functional Features in Patients With Type 2 Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction:A Study Based on Propensity Score Matching]. Peng KL; Liu YM; Jia XY; Wang H; Gou CL; Xue LL; Zou Q; Zhang WJ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Apr; 45(2):264-272. PubMed ID: 37157074 [TBL] [Abstract][Full Text] [Related]
22. Long-term prescription of beta-blocker delays the progression of heart failure with preserved ejection fraction in patients with hypertension: A retrospective observational cohort study. Gu J; Fan YQ; Bian L; Zhang HL; Xu ZJ; Zhang Y; Chen QZ; Yin ZF; Xie YS; Wang CQ Eur J Prev Cardiol; 2016 Sep; 23(13):1421-8. PubMed ID: 26915580 [TBL] [Abstract][Full Text] [Related]
23. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. Paulus WJ; Tschöpe C J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677 [TBL] [Abstract][Full Text] [Related]
24. Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities. Adir Y; Guazzi M; Offer A; Temporelli PL; Cannito A; Ghio S Am Heart J; 2017 Oct; 192():120-127. PubMed ID: 28938958 [TBL] [Abstract][Full Text] [Related]
25. Right ventricular function in heart failure with preserved ejection fraction: a community-based study. Mohammed SF; Hussain I; AbouEzzeddine OF; Takahama H; Kwon SH; Forfia P; Roger VL; Redfield MM Circulation; 2014 Dec; 130(25):2310-20. PubMed ID: 25391518 [TBL] [Abstract][Full Text] [Related]
26. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial. Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925 [TBL] [Abstract][Full Text] [Related]
27. Relation Between Echocardiogram-Based Cardiac Parameters and Outcome in Heart Failure With Preserved and Reduced Ejection Fraction. Obokata M; Takeuchi M; Negishi K; Ohte N; Izumo M; Yamashita E; Ebato M; Yuda S; Kurabayashi M; Nakatani S Am J Cardiol; 2016 Nov; 118(9):1356-1362. PubMed ID: 27600459 [TBL] [Abstract][Full Text] [Related]
28. Contributions of Nondiastolic Factors to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction. Kosmala W; Rojek A; Przewlocka-Kosmala M; Mysiak A; Karolko B; Marwick TH J Am Coll Cardiol; 2016 Feb; 67(6):659-670. PubMed ID: 26868691 [TBL] [Abstract][Full Text] [Related]
29. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. van Veldhuisen DJ; Linssen GC; Jaarsma T; van Gilst WH; Hoes AW; Tijssen JG; Paulus WJ; Voors AA; Hillege HL J Am Coll Cardiol; 2013 Apr; 61(14):1498-506. PubMed ID: 23500300 [TBL] [Abstract][Full Text] [Related]
30. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction. Melenovsky V; Hwang SJ; Redfield MM; Zakeri R; Lin G; Borlaug BA Circ Heart Fail; 2015 Mar; 8(2):295-303. PubMed ID: 25593126 [TBL] [Abstract][Full Text] [Related]
31. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial). Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228 [TBL] [Abstract][Full Text] [Related]
32. New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study. Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Drouet E; Linde C; Daubert C; Eur J Heart Fail; 2015 Jul; 17(7):680-8. PubMed ID: 26033771 [TBL] [Abstract][Full Text] [Related]
33. Analysis of circumferential and longitudinal left ventricular systolic function in patients with non-ischemic chronic heart failure and preserved ejection fraction (from the CARRY-IN-HFpEF study). Cioffi G; Senni M; Tarantini L; Faggiano P; Rossi A; Stefenelli C; Russo TE; Alessandro S; Furlanello F; de Simone G Am J Cardiol; 2012 Feb; 109(3):383-9. PubMed ID: 22112740 [TBL] [Abstract][Full Text] [Related]
34. Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial. Edelmann F; Musial-Bright L; Gelbrich G; Trippel T; Radenovic S; Wachter R; Inkrot S; Loncar G; Tahirovic E; Celic V; Veskovic J; Zdravkovic M; Lainscak M; Apostolović S; Neskovic AN; Pieske B; Düngen HD; JACC Heart Fail; 2016 Feb; 4(2):140-149. PubMed ID: 26682793 [TBL] [Abstract][Full Text] [Related]
35. Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction In Patients With Resistant Hypertension and Type 2 Diabetes Mellitus. Manukyan MA; Falkovskaya AY; Zyubanova IV; Lichikaki VA; Tsoi EI; Ryabova TR; Gusakova AM; Suslova TE; Mordovin VF Kardiologiia; 2022 Aug; 62(8):11-18. PubMed ID: 36066982 [TBL] [Abstract][Full Text] [Related]
36. How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial. Maisel AS; Shah KS; Barnard D; Jaski B; Frivold G; Marais J; Azer M; Miyamoto MI; Lombardo D; Kelsay D; Iqbal N; Taub PR; Kupfer K; Lee E; Clopton P; Zile M; Greenberg B J Card Fail; 2016 Apr; 22(4):283-93. PubMed ID: 26433086 [TBL] [Abstract][Full Text] [Related]
37. Preload-corrected dynamic Starling mechanism in patients with heart failure with preserved ejection fraction. Hieda M; Howden E; Shibata S; Tarumi T; Lawley J; Hearon CM; Palmer D; Fu Q; Zhang R; Sarma S; Levine BD J Appl Physiol (1985); 2018 Jan; 124(1):76-82. PubMed ID: 29051333 [TBL] [Abstract][Full Text] [Related]
38. Prevalence and correlates of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in elderly community residents. Cui X; Zhou J; Jin X; Zhou J; Fu M; Hu K; Sun A; Ge J Int J Cardiol; 2017 Jan; 227():820-825. PubMed ID: 27836303 [TBL] [Abstract][Full Text] [Related]
39. Left atrial strain in heart failure with preserved ejection fraction. Aung SM; Güler A; Güler Y; Huraibat A; Karabay CY; Akdemir I Herz; 2017 Apr; 42(2):194-199. PubMed ID: 27352132 [TBL] [Abstract][Full Text] [Related]
40. The correlation of left atrial volume index to the level of N-terminal pro-BNP in heart failure with a preserved ejection fraction. Kim H; Jun DW; Cho YK; Nam CW; Han SW; Hur SH; Kim YN; Kim KB Echocardiography; 2008 Oct; 25(9):961-7. PubMed ID: 18771554 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]